Trials / Completed
CompletedNCT04340999
Electrophysiological Evaluation of Motor Dysfunction in Liver Cirrhotic Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 56 (actual)
- Sponsor
- Kasr El Aini Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
cross sectional observational study, aimed to assess the electrophysiological function of the motor units in liver cirrhotic patients.
Detailed description
Liver cirrhosis is a global health problem which could be associated with several neurological manifestations. The associated peripheral neuropathy could be assessed by conventional nerve conduction studies. Objective: The study aims at early detection of peripheral neuropathy among patients of liver cirrhosis by conventional nerve conduction studies and quantitative EMG methods. In addition, the study aims at finding out correlation between peripheral neuropathy and severity of the liver cirrhosis. Methods: This a cross-sectional study conducted on fifty-six liver cirrhotic patients, that had been recruited from the Endemic medicine department/outpatient clinics and their age-gender matched sixty-one healthy controls. The recruited patients were clinically assessed .Both conventional nerve conduction studies and quantitative EMG techniques in the form of MUNE calculation, using modified spike -triggered technique and IPA ratio evaluation were performed for the allocated cirrhotic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Nerve conduction studies and Quantitative EMG ( MUNE and IPA) | Nerve Conduction Studies: Electrophysiological method that tests the presence/absence of peripheral neuropathy. MUNE: Electrophysiological technique that assess number of motor units. IPA: Electrophysiological method that assess interference pattern and hence, borderline cases of neuropathy/ myopathy |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2019-12-31
- Completion
- 2020-03-05
- First posted
- 2020-04-10
- Last updated
- 2020-04-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04340999. Inclusion in this directory is not an endorsement.